the ANRS CO21 " Extreme " Cohort (CODEX)
ConditionHIV Infection
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorANRS, Emerging Infectious Diseases
About this trial
A consortium of research teams has studied the immunovirological characteristics of these patients:
The ANRS CO15 ALT cohort The ANRS CO18 HIV Controller cohort the ANRS EP47 VISCONTI study
Eligibility criteria
Qualifiers
Patient infected with HIV-1 and not co-infected with HIV-2
Age ≥ 18 at enrollment
Able to give written consent
Covered by French Social Security
Disqualifiers
None
Trial design
Treatments tested in this trial
- blood sampling
Treatment groups
450 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov